目的 通过研究冠状动脉粥样硬化性心脏病(冠心病)患者血浆氧化型低密度脂蛋白(oxidized low-densitylipoprotein cholesterol,OX-LDL-C)和同型半胱氨酸(homoeysteine,HCY)浓度与Gensini评分的相关性,探讨其对冠状动脉病变严重程度的预测价值.方法 选择疑似冠心病患者86例,据冠状动脉造影结果分为冠心病组(67例)及对照组(19例),冠心病组根据Gensini评分分为轻度亚组(23例)、中度亚组(22例)和重度亚组(22例).分析各组血浆OX-LDL-C和HCY浓度与Gensini评分的相关性.结果 (1)冠心病组与对照组血浆OX-LDL-C、HCY浓度比较,冠心病组较高,差异有统计学意义(P<0.05).(2) Gensini评分三个亚组间血浆OX-LDL-C和HCY浓度比较,差异有统计学意义(P<0.05);随着冠状动脉狭窄程度加重,血浆OX-LDL-C、HCY浓度有增高趋势,差异有统计学意义(P<0.05).(3) Gensini评分与血浆OX-LDL-C(r=0.805,P<0.01)、HCY (r=0.700,P<0.01)浓度呈正相关,且OX-LDL-C与Gensini评分相关性较HCY高;血浆OX-LDL-C与HCY浓度呈正相关(r=0.698,P<0.01).结论 血浆OX-LDL-C和HCY浓度与Gensini评分有关,血浆OX-LDL-C与HCY具有相关一致性,联合检测血浆OX-LDL-C和HCY浓度可更好地了解病情、指导治疗及判断预后.
Objectives To investigate the clinical significance of plasma concentrations of oxidized low-density lipoprotein cholesterol (OX-LDL-C) and homocysteine (HCY) in patients with coronary heart diseases (CHD).Methods Totally 86 cases were divided into coronary heart disease group (n=67) and control group (n=19) according to the results of coronary angiographic examination.Patients in CHD group were further divided into mild subgroup (n=23),moderate subgroup (n=22) and sever subgroup (n=22) according to Gensini score.Plasma concentrations of OX-LDL-C and HCY were measured and their correlations with coronary artery lesions were analyzed.Results (1) Plasma concentrations of OX-LDL-C and HCY were significantly higher in CHD group than those in control group (P〈0.05).(2) Differences in plasma concentrations of OX-LDL-C and HCY of the three subgroups were obvious.They increased by the severity of coronary artery stenoses (P〈0.05).(3) Plasma concentrations of OX-LDL-C (r=0.805,P〈0.01) and HCY (r=0.700,P〈0.01) were positively related with Gensini score in patients with CHD.A significant positive correlation was found between plasma concentrations of OX-LDL-C and HCY (r=0.698,P〈0.01).Conclusions Plasma concentrations of OX-LDL-C and HCY are closely related to coronary atherosclerosis,which suggests that OX-LDL-C and HCY may be indicators to evaluate the severity of coronary artery stenoses.